An interventional study of Mobile Application and Population Management System in Arthritis and Rheumatoid Arthritis, sponsored by Brigham and Women's Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-18.
Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Supportive care
The overall objective of this proposal is to implement a smart phone application (app) + population management system to monitor rheumatoid arthritis (RA) disease activity between scheduled physician office visits. The population management system includes: 1) a web-based dashboard that consolidates incoming patient-reported data using pre-programmed algorithms to identify increases in disease activity, and 2) the population manager, a trained individual who monitors the web-based dashboard and connects patients with their healthcare providers (HCPs). The investigators central hypothesis is that the combined smart phone app + population management system will improve patient satisfaction and management of RA disease activity.
3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.
This study's enrollment of 190 is above the median of 90 across 2,377 interventional studies indexed under Arthritis.
Browse Arthritis studies →Brigham and Women's Hospital is the lead sponsor of 1,236 studies on the registry; 224 are open to participants now.
Of its 116 completed or terminated interventional studies of FDA-regulated products, 64 (55%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This arm of the study will contain half the study population after randomization. The participants in this arm will receive the mobile application with daily questions after the first visit. A population manager will review patient-reported symptoms via a web-base dashboard and contact the subject based on pre-specified guidelines.
Other: Mobile Application · Other: Population Management System
This arm of the study will contain half the study population after randomization. The participants in this arm will not receive the mobile application after the first visit. Although participants will be provided with the contact information of a study staff member, there will be no active contact with the subject unless he/she initiates.
A mobile health application that asks daily questions about participants' pain, function, and disease activity.
Study staff will act as care managers behind a web-based dashboard to monitor participants' responses to the daily questions on the mobile application and connect them with their HCPs.
Treatment Satisfaction Questionnaire for Medication (TSQM)
Time frame: 6 months
Clinical Disease Activity Index (CDAI)
Time frame: 6 months
Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI)
Time frame: 6 months
Patient Activity Scale-II (PAS-II)
Time frame: 6 months
Flare Assessment in Rheumatoid Arthritis (FLARE) questionnaire
Time frame: 6 months
Plan to share: No
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham and Women's Hospital